UK markets closed
  • NIKKEI 225

    23,474.27
    -165.19 (-0.70%)
     
  • HANG SENG

    24,786.13
    +31.71 (+0.13%)
     
  • CRUDE OIL

    40.65
    +0.62 (+1.55%)
     
  • GOLD FUTURES

    1,906.20
    -23.30 (-1.21%)
     
  • DOW

    28,390.44
    +179.62 (+0.64%)
     
  • BTC-GBP

    9,960.39
    +1,538.80 (+18.27%)
     
  • CMC Crypto 200

    262.95
    +6.85 (+2.67%)
     
  • ^IXIC

    11,507.78
    +23.09 (+0.20%)
     
  • ^FTAS

    3,268.54
    +7.53 (+0.23%)
     

Clinical Trials Market Research Report by Design, by Phase, by Indication - Global Forecast to 2025 - Cumulative Impact of COVID-19

ReportLinker
·5-min read

Clinical Trials Market Research Report by Design (Observational Study and Treatment Study), by Phase (Phase I, Phase II, Phase III, and Phase IV), by Indication - Global Forecast to 2025 - Cumulative Impact of COVID-19

New York, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Clinical Trials Market Research Report by Design, by Phase, by Indication - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05940155/?utm_source=GNW

The Global Clinical Trials Market is expected to grow from USD 41,963.49 Million in 2019 to USD 68,854.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.60%.

Market Segmentation & Coverage:
This research report categorizes the Clinical Trials to forecast the revenues and analyze the trends in each of the following sub-markets:

"The Treatment Study is projected to witness the highest growth during the forecast period"

Based on Design, the Clinical Trials Market studied across Observational Study and Treatment Study. The Observational Study further studied across Case Control Study, Cohort Study, Cross Sectional Study, and Ecological Study. The Treatment Study further studied across Adaptive Clinical Trial, Non-randomized Control Trial, and Randomized Control Trial. The Observational Study commanded the largest size in the Clinical Trials Market in 2019. On the other hand, the Treatment Study is expected to grow at the fastest CAGR during the forecast period.

"The Phase II is projected to witness the highest growth during the forecast period"

Based on Phase, the Clinical Trials Market studied across Phase I, Phase II, Phase III, and Phase IV. The Phase III commanded the largest size in the Clinical Trials Market in 2019. On the other hand, the Phase II is expected to grow at the fastest CAGR during the forecast period.

"The Oncology is projected to witness the highest growth during the forecast period"

Based on Indication, the Clinical Trials Market studied across Autoimmune/Inflammation, CNS condition, Cardiovascular, Diabetes, Obesity, Oncology, and Pain management. The Autoimmune/Inflammation commanded the largest size in the Clinical Trials Market in 2019. On the other hand, the Oncology is expected to grow at the fastest CAGR during the forecast period.

Based on Geography, the Clinical Trials Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Trials Market including Charles River Laboratory, Chiltern International Ltd., Clinipace, Eli Lilly and Company, ICON PLC, IQVIA, Novo Nordisk A/S, PAREXEL International Corporation, Pfizer Inc., Pharmaceutical Product Development, LLC, PRA Health Sciences, SGS SA, Syneos Health, and Wuxi AppTec Inc..

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Trials Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Clinical Trials Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Trials Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Trials Market?
4. What is the competitive strategic window for opportunities in the Global Clinical Trials Market?
5. What are the technology trends and regulatory frameworks in the Global Clinical Trials Market?
6. What are the modes and strategic moves considered suitable for entering the Global Clinical Trials Market?
Read the full report: https://www.reportlinker.com/p05940155/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001